Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan · Delayed Price · Currency is JPY 6,040.00
0.00 (0.00%)
Inactive · Last trade price on May 8, 2026
TYO:4530 Financials Overview
Financials in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Feb '26 Feb 28, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Revenue Revenue Growth | 163,024 | 163,024 | 156,006 | 141,706 | 128,330 | 120,193 |
Revenue Growth | 4.50% | 4.50% | 10.09% | 10.42% | 6.77% | 4.96% |
Gross Profit Gross Profit Growth | 96,121 | 96,121 | 91,196 | 78,971 | 72,700 | 70,067 |
Operating Income Operating Income Growth | 17,918 | 17,918 | 18,896 | 13,168 | 11,601 | 9,337 |
Net Income Net Income Growth | 19,160 | 19,160 | 21,758 | 13,969 | 11,742 | 9,658 |
Earnings Per Share EPS Growth | 268.22 | 268.22 | 295.15 | 181.42 | 147.88 | 118.84 |
EPS Growth | -9.12% | -9.12% | 62.69% | 22.68% | 24.44% | 5.07% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Feb '26 Feb 28, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Pharmaceuticals Business Pharmaceuticals Business Growth | 153,600 | 163,024 | - | 138,455 | 125,202 | 117,291 |
Others Others Growth | 3,143 | - | 3,352 | 3,251 | 3,127 | 2,901 |
Medicine and Related Product Business Medicine and Related Product Business Growth | - | - | 152,654 | - | - | - |
Total Total Growth | 156,743 | 163,024 | 156,006 | 141,706 | 128,329 | 120,192 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Feb '26 Feb 28, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Cash & Investments Cash & Investments Growth | 118,638 | 118,638 | 129,116 | 125,321 | 136,868 | 142,431 |
Total Debt Total Debt Growth | 2,375 | 2,375 | 3,856 | 2,100 | 2,295 | 2,460 |
Net Cash (Debt) Net Cash Growth | 116,263 | 116,263 | 125,260 | 123,221 | 134,573 | 139,971 |
Net Cash Growth | -7.18% | -7.18% | 1.65% | -8.44% | -3.86% | 4.15% |
Net Cash Per Share Net Cash Per Share Growth | 1627.51 | 1627.51 | 1699.18 | 1600.21 | 1694.75 | 1722.30 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Feb '26 Feb 28, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 17,478 | 17,478 | 18,765 | 18,188 | 12,727 | 19,199 |
Capital Expenditures CapEx Growth | -7,995 | -7,995 | -13,627 | -12,924 | -7,859 | -3,610 |
Free Cash Flow Free Cash Flow Growth | 9,483 | 9,483 | 5,138 | 5,264 | 4,868 | 15,589 |
Free Cash Flow Growth | 84.57% | 84.57% | -2.39% | 8.13% | -68.77% | 700.26% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Feb '26 Feb 28, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Gross Margin | 58.96% | 58.96% | 58.46% | 55.73% | 56.65% | 58.29% |
Operating Margin | 10.99% | 10.99% | 12.11% | 9.29% | 9.04% | 7.77% |
Pretax Margin | 14.51% | 14.51% | 18.39% | 13.54% | 12.56% | 10.78% |
Profit Margin | 11.75% | 11.75% | 13.95% | 9.86% | 9.15% | 8.04% |
FCF Margin | 5.82% | 5.82% | 3.29% | 3.72% | 3.79% | 12.97% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Dividend Per Share Dividend Per Share Growth | 45.000 | 45.000 | 86.000 | 85.000 | 84.000 | 84.000 |
Dividend Per Share Growth | 20.00% | -47.67% | 1.18% | 1.19% | 0% | 0.60% |
Dividend Yield | 0.74% | 0.75% | 2.07% | 2.27% | 2.32% | 2.48% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
PE Ratio | 22.52 | 22.05 | 14.16 | 21.01 | 25.86 | 30.75 |
Forward PE | 35.05 | 24.70 | 16.20 | 18.33 | 23.68 | 27.63 |
P/FCF Ratio | 44.84 | 44.56 | 59.96 | 55.74 | 62.38 | 19.05 |
PS Ratio | 2.61 | 2.59 | 1.98 | 2.07 | 2.37 | 2.47 |